• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    PharmAthene, Inc. (PIP)

    -NYSE MKT
    1.84 0.12(6.98%) Dec 19, 4:05PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 17,913   25,176   24,266  
    Cost of Revenue -   -   -  
    Gross Profit 17,913   25,176   24,266  
    Operating Expenses
    Research Development15,290  19,510  21,220  
    Selling General and Administrative13,279  11,629  14,311  
    Non Recurring -   -   -  
    Others182  304  461  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (10,839) (6,266) (11,726)
    Income from Continuing Operations
    Total Other Income/Expenses Net(448)1,884  7,983  
    Earnings Before Interest And Taxes(11,287)(4,382)(3,743)
    Interest Expense369  343  55  
    Income Before Tax(11,657)(4,725)(3,798)
    Income Tax Expense62  196   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(11,718)(4,920)(3,798)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (11,718) (4,920) (3,798)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (11,718) (4,920) (3,798)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.